688163 赛伦生物
已收盘 04-10 15:00:01
资讯
新帖
简况
3月30日赛伦生物涨6.06%，易方达丰惠混合基金重仓该股
证券之星 · 03-30
3月30日赛伦生物涨6.06%，易方达丰惠混合基金重仓该股
赛伦生物（688163）披露关于使用自有资金支付募投项目人员费用并以募集资金等额置换的公告，3月23日股价下跌2.99%
证券之星 · 03-23
赛伦生物（688163）披露关于使用自有资金支付募投项目人员费用并以募集资金等额置换的公告，3月23日股价下跌2.99%
每周股票复盘：赛伦生物（688163）拟用5亿闲置募资做现金管理
证券之星 · 03-22
每周股票复盘：赛伦生物（688163）拟用5亿闲置募资做现金管理
每周股票复盘：赛伦生物（688163）2025年净利增16.76%
证券之星 · 03-01
每周股票复盘：赛伦生物（688163）2025年净利增16.76%
赛伦生物（688163）披露2025年度业绩快报公告，2月26日股价下跌0.31%
证券之星 · 02-26
赛伦生物（688163）披露2025年度业绩快报公告，2月26日股价下跌0.31%
赛伦生物(688163.SH)2025年度归母净利润5171.35万元，同比增长16.76%
智通财经 · 02-26
赛伦生物(688163.SH)2025年度归母净利润5171.35万元，同比增长16.76%
赛伦生物：公司将结合自身发展需求及外部环境条件，持续关注并积极寻求优质的并购标的
证券日报 · 01-30
赛伦生物：公司将结合自身发展需求及外部环境条件，持续关注并积极寻求优质的并购标的
每周股票复盘：赛伦生物（688163）变更签字注册会计师
证券之星 · 2025-12-28
每周股票复盘：赛伦生物（688163）变更签字注册会计师
赛伦生物（688163）披露关于变更签字注册会计师的公告，12月25日股价上涨0.41%
证券之星 · 2025-12-25
赛伦生物（688163）披露关于变更签字注册会计师的公告，12月25日股价上涨0.41%
【私募调研记录】寿宁投资调研赛伦生物
证券之星 · 2025-12-01
【私募调研记录】寿宁投资调研赛伦生物
赛伦生物：11月14日进行路演，众合旭科技、JadeValue等多家机构参与
证券之星 · 2025-11-28
赛伦生物：11月14日进行路演，众合旭科技、JadeValue等多家机构参与
每周股票复盘：赛伦生物（688163）将参加2025年11月13日业绩说明会
证券之星 · 2025-11-09
每周股票复盘：赛伦生物（688163）将参加2025年11月13日业绩说明会
赛伦生物（688163）披露参加2025年上海辖区上市公司三季报集体业绩说明会的公告，11月03日股价下跌0.08%
证券之星 · 2025-11-03
赛伦生物（688163）披露参加2025年上海辖区上市公司三季报集体业绩说明会的公告，11月03日股价下跌0.08%
赛伦生物（688163）2025年三季报简析：营收净利润同比双双增长
证券之星 · 2025-10-29
赛伦生物（688163）2025年三季报简析：营收净利润同比双双增长
股市必读：赛伦生物三季报 - 第三季度单季净利润同比增长1.94%
证券之星 · 2025-10-28
股市必读：赛伦生物三季报 - 第三季度单季净利润同比增长1.94%
赛伦生物(688163.SH)发布前三季度业绩，归母净利润6421万元，同比增长2.01%
智通财经 · 2025-10-27
赛伦生物(688163.SH)发布前三季度业绩，归母净利润6421万元，同比增长2.01%
赛伦生物收盘下跌2.08%，滚动市盈率42.70倍，总市值19.38亿元
金融界 · 2025-03-07
赛伦生物收盘下跌2.08%，滚动市盈率42.70倍，总市值19.38亿元
赛伦生物2024年度业绩快报：归母净利润增17.08%
财中社 · 2025-02-25
赛伦生物2024年度业绩快报：归母净利润增17.08%
赛伦生物发布2024年度业绩快报，盈利0.454亿元
证券之星 · 2025-02-25
赛伦生物发布2024年度业绩快报，盈利0.454亿元
加载更多
公司概况
公司名称：
上海赛伦生物技术股份有限公司
所属行业：
医药制造业
上市日期：
2022-03-11
主营业务：
上海赛伦生物技术股份有限公司的主营业务是研究、开发、生产及销售针对生物毒素及生物安全领域的预防和治疗药物以及快速诊断产品。公司的主要产品是抗蝮蛇毒血清、抗五步蛇毒血清、抗眼镜蛇毒血清、抗银环蛇毒血清、马破伤风免疫球蛋白(F(ab')2)、抗狂犬病血清。
发行价格：
33.03
{"stockData":{"symbol":"688163","market":"SH","secType":"STK","nameCN":"赛伦生物","latestPrice":30.55,"timestamp":1775804401000,"preClose":29.92,"halted":0,"volume":2497609,"delay":0,"changeRate":0.0211,"floatShares":108000000,"shares":108000000,"eps":0.421,"marketStatus":"已收盘","change":0.63,"latestTime":"04-10 15:00:01","open":29.91,"high":30.97,"low":29.4,"amount":75443000,"amplitude":0.0525,"askPrice":30.58,"askSize":39,"bidPrice":30.55,"bidSize":36,"shortable":0,"etf":0,"ttmEps":0.421,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1776043800000},"marketStatusCode":5,"adr":0,"adjPreClose":29.92,"symbolType":"stock_kcb","openAndCloseTimeList":[[1775784600000,1775791800000],[1775797200000,1775804400000]],"highLimit":32.91,"lowLimit":26.93,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":108220000,"isCdr":false,"pbRate":2.94,"roa":"--","peRate":72.565321,"roe":"5.71%","epsLYR":0.41,"committee":-0.364407,"marketValue":3306000000,"turnoverRate":0.0231,"status":0,"afterMarket":{"amount":0,"volume":0,"close":30.55,"buyVolume":0,"sellVolume":0,"time":1775806437558,"indexStatus":"已收盘 04-10 15:30:00","preClose":29.92},"floatMarketCap":3306000000},"requestUrl":"/m/hq/s/688163","defaultTab":"news","newsList":[{"id":"2623397234","title":"3月30日赛伦生物涨6.06%，易方达丰惠混合基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2623397234","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623397234?lang=zh_cn&edition=full","pubTime":"2026-03-30 16:25","pubTimestamp":1774859115,"startTime":"0","endTime":"0","summary":"证券之星消息，3月30日赛伦生物涨6.06%，收盘报26.95元，换手率3.58%，成交量3.87万手，成交额1.02亿元。重仓赛伦生物的公募基金请见下表：根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为易方达基金的易方达丰惠混合。易方达丰惠混合目前规模为0.98亿元，最新净值1.419，较上一交易日上涨0.5%，近一年上涨2.89%。该公募基金现任基金经理为罗川。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026033000021315.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688163","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621774983","title":"赛伦生物（688163）披露关于使用自有资金支付募投项目人员费用并以募集资金等额置换的公告，3月23日股价下跌2.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621774983","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621774983?lang=zh_cn&edition=full","pubTime":"2026-03-23 17:56","pubTimestamp":1774259769,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘，赛伦生物报收于22.03元，较前一交易日下跌2.99%，最新总市值为23.84亿元。该股当日开盘22.41元，最高22.73元，最低21.88元，成交额达4721.44万元，换手率为1.96%。公司于近日披露《关于使用自有资金支付募投项目人员费用并以募集资金等额置换的公告》。同意公司在募投项目实施期间，先行使用自有资金支付项目人员薪酬等费用，后续定期从募集资金专户划转等额资金至公司自有账户进行置换。上述事项无需提交股东大会审议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300028306.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688163"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621468799","title":"每周股票复盘：赛伦生物（688163）拟用5亿闲置募资做现金管理","url":"https://stock-news.laohu8.com/highlight/detail?id=2621468799","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621468799?lang=zh_cn&edition=full","pubTime":"2026-03-22 03:06","pubTimestamp":1774119973,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘，赛伦生物报收于22.71元，较上周的24.03元下跌5.49%。本周关注点公司公告汇总：赛伦生物拟使用最高不超过5亿元的暂时闲置募集资金进行现金管理。方正证券承销保荐有限责任公司关于上海赛伦生物技术股份有限公司使用部分暂时闲置募集资金进行现金管理的核查意见上海赛伦生物技术股份有限公司拟使用不超过5亿元的暂时闲置募集资金进行现金管理，期限自董事会审议通过之日起不超过12个月，资金可循环滚动使用。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032200000851.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688163","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616437458","title":"每周股票复盘：赛伦生物（688163）2025年净利增16.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616437458","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616437458?lang=zh_cn&edition=full","pubTime":"2026-03-01 02:20","pubTimestamp":1772302824,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘，赛伦生物报收于25.5元，较上周的26.03元下跌2.04%。本周，赛伦生物2月25日盘中最高价报26.47元。本周关注点来自业绩披露要点：赛伦生物2025年归属净利润同比增长16.76%。业绩披露要点赛伦生物近日即将发布2025年年报，根据2月26日发布的业绩快报，归属净利润盈利0.517亿元，同比增长16.76%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100000776.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688163"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614025365","title":"赛伦生物（688163）披露2025年度业绩快报公告，2月26日股价下跌0.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614025365","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614025365?lang=zh_cn&edition=full","pubTime":"2026-02-26 23:04","pubTimestamp":1772118259,"startTime":"0","endTime":"0","summary":"截至2026年2月26日收盘，赛伦生物报收于25.92元，较前一交易日下跌0.31%，最新总市值为28.05亿元。该股当日开盘26.39元，最高26.39元，最低25.7元，成交额达2921.77万元，换手率为1.04%。近日，上海赛伦生物技术股份有限公司发布2025年度业绩快报，营业总收入19,620.59万元，同比增长0.66%；营业利润6,204.00万元，同比增长19.34%；归属于母公司所有者的净利润5,171.35万元，同比增长16.76%；扣除非经常性损益的净利润4,255.89万元，同比增长50.65%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600037650.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688163"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614901369","title":"赛伦生物(688163.SH)2025年度归母净利润5171.35万元，同比增长16.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614901369","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614901369?lang=zh_cn&edition=full","pubTime":"2026-02-26 16:34","pubTimestamp":1772094876,"startTime":"0","endTime":"0","summary":"智通财经APP讯，赛伦生物(688163.SH)发布2025年度业绩快报，2025年度实现营业总收入1.96亿元，同比增长0.66%;实现归属于母公司所有者的净利润5171.35万元，同比增长16.76%。2025年度，公司营业收入微增，毛利率基本持平。2025年下半年挂网上市的抗狂犬病血清处于上市销售初期，尚未在报告期形成显著收入贡献。本期净利润同比增长，主要系2024年度公司对联营企业上海赛远生物科技有限公司确认了投资亏损并对长期股权投资余额全额计提减值准备，以及本期非经常性损益同比减少、研发费用同比减少等因素综合影响所致。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1407584.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"赛伦生物(688163.SH)2025年度归母净利润5171.35万元，同比增长16.76%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688163"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607015012","title":"赛伦生物：公司将结合自身发展需求及外部环境条件，持续关注并积极寻求优质的并购标的","url":"https://stock-news.laohu8.com/highlight/detail?id=2607015012","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607015012?lang=zh_cn&edition=full","pubTime":"2026-01-30 19:06","pubTimestamp":1769771160,"startTime":"0","endTime":"0","summary":"主要原因系公司主要产品抗蛇毒血清和马破伤风免疫球蛋白的适应症发生率具有显著的季节性，蛇伤、外伤均在夏季高发，第二、三季度销量较大，第一、四季度销量较小，各季度的销售收入随之呈现出显著的季节性起伏。公司将结合自身发展需求及外部环境条件，持续关注并积极寻求优质的并购标的，促进公司主业的外延式发展。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-01-30/doc-inhkauvf3557333.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-01-30/doc-inhkauvf3557333.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","688163"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594906247","title":"每周股票复盘：赛伦生物（688163）变更签字注册会计师","url":"https://stock-news.laohu8.com/highlight/detail?id=2594906247","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594906247?lang=zh_cn&edition=full","pubTime":"2025-12-28 05:17","pubTimestamp":1766870230,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，赛伦生物报收于21.69元，较上周的22.24元下跌2.47%。本周，赛伦生物12月22日盘中最高价报22.41元。赛伦生物当前最新总市值23.47亿元，在生物制品板块市值排名51/51，在两市A股市值排名4928/5178。本周关注点公司公告汇总：赛伦生物因内部工作调整，原签字注册会计师金园变更为陈俞宜。陈俞宜自2021年起为注册会计师，2024年开始为公司提供审计服务，近三年无执业处罚记录，具备独立性。本次变更不影响公司2025年度审计工作的正常进行。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122800001428.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688163","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594923067","title":"赛伦生物（688163）披露关于变更签字注册会计师的公告，12月25日股价上涨0.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594923067","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594923067?lang=zh_cn&edition=full","pubTime":"2025-12-25 23:07","pubTimestamp":1766675239,"startTime":"0","endTime":"0","summary":"截至2025年12月25日收盘，赛伦生物报收于22.15元，较前一交易日上涨0.41%，最新总市值为23.97亿元。近日，赛伦生物发布公告称，因天职国际会计师事务所内部工作调整，原签字注册会计师金园变更为陈俞宜，项目合伙人仍为郭海龙，项目质量复核人为张磊。陈俞宜自2021年起为注册会计师，2024年开始为公司提供审计服务，近三年无执业处罚记录，具备独立性。本次变更不影响公司2025年度审计工作的正常进行。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500036649.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688163","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2588571934","title":"【私募调研记录】寿宁投资调研赛伦生物","url":"https://stock-news.laohu8.com/highlight/detail?id=2588571934","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588571934?lang=zh_cn&edition=full","pubTime":"2025-12-01 08:01","pubTimestamp":1764547268,"startTime":"0","endTime":"0","summary":"根据市场公开信息及11月28日披露的机构调研信息，知名私募寿宁投资近期对1家上市公司进行了调研，相关名单如下：1）赛伦生物 调研纪要：公司除抗蛇毒血清外，还拥有马破伤风免疫球蛋白和抗狂犬病血清产品，并布局新型抗体、重组蛋白等技术平台，研发广谱抗蛇毒抗体等新药。募投项目扩建生产线位于上海青浦厂区，预计2026年建成，将提升产能。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2025120100000215.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688163","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2586789762","title":"赛伦生物：11月14日进行路演，众合旭科技、JadeValue等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2586789762","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586789762?lang=zh_cn&edition=full","pubTime":"2025-11-28 19:31","pubTimestamp":1764329507,"startTime":"0","endTime":"0","summary":"除抗蛇毒血清之外，公司已上市产品还包括用于预防与治疗破伤风的马破伤风免疫球蛋白和用于狂犬病预防的抗狂犬病血清。在抗蛇毒血清的国际市场方面，全球各个国家和地区的主要蛇种各不相同，需要结合各国的毒蛇分布种类和抗血清市场等具体情况来综合考虑。截至目前，公司没有调整抗蛇毒血清产品价格的计划。抗蛇毒血清产品有效期为3年。蛇毒中毒系基于毒素成分对生物体的特异性破坏。截至目前，抗血清仍然是治疗蛇伤的唯一特效药。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112800032717.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688163","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2582646658","title":"每周股票复盘：赛伦生物（688163）将参加2025年11月13日业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2582646658","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582646658?lang=zh_cn&edition=full","pubTime":"2025-11-09 05:02","pubTimestamp":1762635739,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘，赛伦生物报收于24.08元，较上周的24.38元下跌1.23%。本周，赛伦生物11月3日盘中最高价报24.51元。本周关注点公司公告汇总：赛伦生物将于2025年11月13日参加上海辖区上市公司三季报集体业绩说明会。业绩披露要点：公司已于2025年10月28日披露2025年第三季度报告。公司公告汇总：投资者可于2025年11月6日至11月12日16:00前通过上证路演中心或公司邮箱提前提问。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110900001811.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688163","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2580293582","title":"赛伦生物（688163）披露参加2025年上海辖区上市公司三季报集体业绩说明会的公告，11月03日股价下跌0.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580293582","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580293582?lang=zh_cn&edition=full","pubTime":"2025-11-03 17:33","pubTimestamp":1762162422,"startTime":"0","endTime":"0","summary":"截至2025年11月3日收盘，赛伦生物报收于24.36元，较前一交易日下跌0.08%，最新总市值为26.36亿元。近日，赛伦生物发布关于参加2025年上海辖区上市公司三季报集体业绩说明会的公告。投资者可于2025年11月6日至11月12日16:00前通过上证路演中心“提问预征集”栏目或公司邮箱dmb@serum-china.com进行提问。说明会结束后，投资者可通过上证路演中心查看会议情况。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300024309.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688163","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2579915522","title":"赛伦生物（688163）2025年三季报简析：营收净利润同比双双增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2579915522","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579915522?lang=zh_cn&edition=full","pubTime":"2025-10-29 06:17","pubTimestamp":1761689848,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期赛伦生物发布2025年三季报。根据财报显示，赛伦生物营收净利润同比双双增长。截至本报告期末，公司营业总收入1.75亿元，同比上升1.07%，归母净利润6421.07万元，同比上升2.01%。按单季度数据看，第三季度营业总收入7431.92万元，同比下降1.22%，第三季度归母净利润3123.39万元，同比上升1.94%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900008835.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688163"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2578674344","title":"股市必读：赛伦生物三季报 - 第三季度单季净利润同比增长1.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578674344","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578674344?lang=zh_cn&edition=full","pubTime":"2025-10-28 05:54","pubTimestamp":1761602061,"startTime":"0","endTime":"0","summary":"截至2025年10月27日收盘，赛伦生物报收于23.22元，下跌0.13%，换手率0.75%，成交量8146.0手，成交额1892.52万元。来自股本股东变化：截至2025年9月30日，赛伦生物股东户数较6月30日减少14.1%，户均持股数量升至1.63万股。来自业绩披露要点：2025年前三季度赛伦生物归母净利润同比增长2.01%，扣非净利润同比增长12.15%。2025年第三季度单季度主营收入7431.92万元，同比下降1.22%；单季度归母净利润3123.39万元，同比上升1.94%；单季度扣非净利润2790.86万元，同比上升1.43%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800006001.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688163"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2578614415","title":"赛伦生物(688163.SH)发布前三季度业绩，归母净利润6421万元，同比增长2.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578614415","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578614415?lang=zh_cn&edition=full","pubTime":"2025-10-27 18:18","pubTimestamp":1761560322,"startTime":"0","endTime":"0","summary":"智通财经APP讯，赛伦生物(688163.SH)披露2025年第三季度报告，公司前三季度实现营收1.75亿元，同比增长1.07%;归母净利润6421万元，同比增长2.01%;扣非净利润5644万元，同比增长12.15%;基本每股收益0.59元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1360497.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688163"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517348689","title":"赛伦生物收盘下跌2.08%，滚动市盈率42.70倍，总市值19.38亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517348689","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517348689?lang=zh_cn&edition=full","pubTime":"2025-03-07 19:26","pubTimestamp":1741346816,"startTime":"0","endTime":"0","summary":"3月7日，赛伦生物今日收盘17.91元，下跌2.08%，滚动市盈率PE达到42.70倍，总市值19.38亿元。从行业市盈率排名来看，公司所处的生物制品行业市盈率平均41.50倍，行业中值37.52倍，赛伦生物排名第56位。股东方面，截至2024年9月30日，赛伦生物股东户数7139户，较上次增加130户，户均持股市值35.28万元，户均持股数量2.76万股。最新一期业绩显示，2024年三季报，公司实现营业收入1.73亿元，同比4.31%；净利润6294.75万元，同比23.92%，销售毛利率78.83%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/03/07192648599815.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","688163"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514503470","title":"赛伦生物2024年度业绩快报：归母净利润增17.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514503470","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514503470?lang=zh_cn&edition=full","pubTime":"2025-02-25 16:34","pubTimestamp":1740472476,"startTime":"0","endTime":"0","summary":"2月25日，赛伦生物发布公告，2024年度业绩快报显示，公司实现营业总收入1.95亿元，同比增长2.51%；营业利润为5219万元，同比增长13.5%；利润总额为5078万元，同比增长11.80%；归母净利润为4540万元，同比增长17.08%；归母净利润扣除非经常性损益后为2936万元，同比增长22.3%。基本每股收益为0.42元，同比增长16.67%。2024年前三季度，赛伦生物实现收入1.73亿元，归母净利润6295万元。文章来源：财中社赛伦生物2024年度业绩快报：归母净利润增17.08%","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225164918abdc1e8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225164918abdc1e8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688163"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514700054","title":"赛伦生物发布2024年度业绩快报，盈利0.454亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514700054","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514700054?lang=zh_cn&edition=full","pubTime":"2025-02-25 16:19","pubTimestamp":1740471567,"startTime":"0","endTime":"0","summary":"证券之星消息，赛伦生物近日即将发布2024年年报，根据2月25日发布的业绩快报，归属净利润盈利0.454亿元，同比增长17.08%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022500027938.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688163","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1775935039792,"stockEarnings":[{"period":"1week","weight":0.0973},{"period":"1month","weight":0.251},{"period":"3month","weight":0.3191},{"period":"6month","weight":0.326},{"period":"1year","weight":0.8828},{"period":"ytd","weight":0.4033}],"compareEarnings":[{"period":"1week","weight":0.0274},{"period":"1month","weight":-0.0356},{"period":"3month","weight":-0.0326},{"period":"6month","weight":0.0229},{"period":"1year","weight":0.2366},{"period":"ytd","weight":0.0044}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海赛伦生物技术股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"6635人(较上一季度减少14.10%)","perCapita":"16310股","listingDate":"2022-03-11","address":"上海市青浦区华青路1288号","registeredCapital":"10822万元","survey":" 上海赛伦生物技术股份有限公司的主营业务是研究、开发、生产及销售针对生物毒素及生物安全领域的预防和治疗药物以及快速诊断产品。公司的主要产品是抗蝮蛇毒血清、抗五步蛇毒血清、抗眼镜蛇毒血清、抗银环蛇毒血清、马破伤风免疫球蛋白(F(ab')2)、抗狂犬病血清。","listedPrice":33.03},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"赛伦生物(688163)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供赛伦生物(688163)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"赛伦生物,688163,赛伦生物股票,赛伦生物股票老虎,赛伦生物股票老虎国际,赛伦生物行情,赛伦生物股票行情,赛伦生物股价,赛伦生物股市,赛伦生物股票价格,赛伦生物股票交易,赛伦生物股票购买,赛伦生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"赛伦生物(688163)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供赛伦生物(688163)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}